LA, P., I, C., JJ, F., WP, B., K, P., M, B., . . . MJ, S. (2026). Prediction of Hepatocellular Carcinoma and Other Liver-Related Events in Chronic Hepatitis B Patients With Metabolic Dysfunction or Metabolic Dysfunction-Associated Steatotic Liver Disease. Alimentary pharmacology & therapeutics, 63(3), 374. https://doi.org/10.1111/apt.70360
Chicago Style (17th ed.) CitationLA, Patmore, et al. "Prediction of Hepatocellular Carcinoma and Other Liver-Related Events in Chronic Hepatitis B Patients With Metabolic Dysfunction or Metabolic Dysfunction-Associated Steatotic Liver Disease." Alimentary Pharmacology & Therapeutics 63, no. 3 (2026): 374. https://doi.org/10.1111/apt.70360.
MLA (9th ed.) CitationLA, Patmore, et al. "Prediction of Hepatocellular Carcinoma and Other Liver-Related Events in Chronic Hepatitis B Patients With Metabolic Dysfunction or Metabolic Dysfunction-Associated Steatotic Liver Disease." Alimentary Pharmacology & Therapeutics, vol. 63, no. 3, 2026, p. 374, https://doi.org/10.1111/apt.70360.
